Are people with Parkinson's disease depressed or demoralized?

April 4, 2018, American Academy of Neurology
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia

People with Parkinson's disease who show signs of depression may actually have a condition called demoralization, according to a study published in the April 4, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. That study found demoralization may be common in Parkinson's disease.

Demoralization is a state of feeling helpless and hopeless, with a self-perceived inability to perform tasks in . With depression, a person usually knows the appropriate course of action and lacks motivation to act. With , a person may feel incompetent and therefore uncertain about the appropriate course of action. The two can occur together.

"The distinction between depression and demoralization is important because the treatments approaches are different," said study author Brian Koo, MD, of Yale University in New Haven, Conn., and a member of the American Academy of Neurology. "Demoralization may be better treated with rather than antidepressant medication, which is often prescribed for depression."

For the study, researchers enrolled a total of 180 with an average age of 68. Of the group, 94 people had Parkinson's disease and 86 people did not. Those in the control group were matched for sex, race, education and age.

Participants were evaluated for demoralization with questionnaires asking questions such as "Do you experience feelings of helplessness, hopelessness or giving up?" and "Do you feel that you have failed to meet your expectations or those of other people?". They were also assessed for depression.

Researchers found that people with Parkinson's disease were 2.6 times more likely to be demoralized than people without the disease. In people with Parkinson's disease, 18 percent, or 17 of 94 people, were demoralized compared to 8 percent, or seven of 86 people in the control group.

Additionally, in the people with Parkinson's disease, 20 percent, or 19 of 94 people, were depressed compared to 4 percent, or three of 86 people in the .

While demoralization and depression can occur at the same time, researchers found there were individuals with just one of the conditions. Among those with Parkinson's disease, 37 percent, or seven out of 19 people with depression were not demoralized. Also, 29 percent, or five out of 17 people who were demoralized were not depressed.

"This suggests that demoralization is not simply a marker of depression," Koo said.

Researchers also found that demoralization, but not , was tied to the inability to control movement.

Koo said, "Since our research shows a link between demoralization and a person's ability to function, more research may help further define how to best treat demoralization in Parkinson's disease."

One limitation of the study was a lack of information on details of employment. Another was that Parkinson's patients with severe disease were more likely to not participate, so the prevalence of demoralization may be underestimated.

Explore further: The role of demoralization in predicting response to psychotherapy

Related Stories

The role of demoralization in predicting response to psychotherapy

February 2, 2016
A report published in the current issue of Psychotherapy and Psychosomatics explores the role of demoralization in predicting response to psychotherapy. In line with the need to deepen the understanding of the psychological ...

People with depression may be more likely to develop Parkinson's disease

May 20, 2015
People with depression may be more likely to develop Parkinson's disease, according to a large study published in the May 20, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

Depression may increase your risk of Parkinson's disease

October 2, 2013
People who are depressed may have triple the risk of developing Parkinson's disease, according to a study published in the October 2, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

Shedding a tear may help diagnose Parkinson's disease

February 22, 2018
Tears may hold clues to whether someone has Parkinson's disease, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to ...

Caffeine level in blood may help diagnose people with Parkinson's disease

January 3, 2018
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology, the medical journal of the ...

Recommended for you

Molecule capable of halting and reverting neurodegeneration caused by Parkinson's disease identified

September 25, 2018
The small SynuClean-D molecule interrupts the formation of the alpha-synuclein amyloid fibres responsible for the onset of Parkinson's disease, and reverts the neurodegeneration caused by the disease. The study, headed by ...

Genomic dark matter activity connects Parkinson's and psychiatric diseases

September 20, 2018
Dopamine neurons are located in the midbrain, but their tendril-like axons can branch far into the higher cortical areas, influencing how we move and how we feel. New genetic evidence has revealed that these specialized cells ...

Gene therapy shown to remove core component of Parkinson's disease

September 14, 2018
An international team led by Rush researcher Jeffrey Kordower, Ph.D., has moved a step closer to developing a treatment to clear brain cells of a protein that is an integral cause of Parkinson's disease. The team published ...

ADHD may increase risk of Parkinson's disease and similar disorders

September 12, 2018
While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder (ADHD), the long-term health effects of having ADHD and of common ADHD medications remains understudied. ...

New high-throughput screening study may open up for future Parkinson's disease therapy

September 11, 2018
Parkinson's disease (PD) is the most common movement disorder in the world. PD patients suffer from shaking, rigidity, slowness of movement and difficulty with walking. It is a neurodegenerative disease caused by the loss ...

Marmosets serve as an effective model for non-motor symptoms of Parkinson's disease

September 5, 2018
Small, New World monkeys called marmosets can mimic the sleep disturbances, changes in circadian rhythm, and cognitive impairment people with Parkinson's disease develop, according to a new study by scientists at Texas Biomedical ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.